Engineered T-cell Receptor T Cells for Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered T-cell Receptor T Cells for Cancer Immunotherapy

Published:2021-11 Issue:11 Volume:9 Page:1252-1261
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Greenbaum Uri^ORCID,Dumbrava Ecaterina I.^ORCID,Biter Amadeo B.,Haymaker Cara L.^ORCID,Hong David S.^ORCID

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations;Blood Advances;2024-08-16

2. First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors;Journal for ImmunoTherapy of Cancer;2024-07

3. CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors;Med;2024-06

4. A Mimicry-Based Strategy Between Human and Commensal Antigens for the Development of a New Family of Immune Therapies for Cancer;2024-06-01

5. Mechanical forces amplify TCR mechanotransduction in T cell activation and function;Applied Physics Reviews;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP